{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
nonoxynol-9
to a specific field?
Status:
Investigational
Source:
NCT03775538: Phase 1/Phase 2 Interventional Completed Parkinson Disease
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01868022: Phase 1 Interventional Completed Neoplasms
(2013)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
INN:gozanertinib [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02298946: Phase 1 Interventional Completed Colorectal Cancer
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02603952: Phase 1/Phase 2 Interventional Completed Influenza
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02221882: Phase 1 Interventional Completed Neoplasms
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT00970580: Phase 1 Interventional Completed Non-Small Cell Lung Cancer
(2009)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03804944: Phase 2 Interventional Recruiting Breast Cancer
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT00363714: Phase 1/Phase 2 Interventional Completed Age-Related Macular Degeneration
(2004)
Source URL:
Class:
CONCEPT
Status:
Designated
Source:
FDA ORPHAN DRUG:883922
Source URL:
Class:
CONCEPT